Avalyn Pharma
PublicAvalyn Pharma is now publicly traded
The data on this page reflects Avalyn Pharma's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 1, 2026
Last Round
Series D
Jul 22, 2025
Total Funding Raised
$574.3M
Company Overview
Avalyn Pharma is a biopharmaceutical company that develops inhaled therapies for the treatment of rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
Avalyn Pharma Comparables
Compare Avalyn Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Calluna Pharma | 56% | |
| InCarda Therapeutics | 56% | |
| FibroNox | 55% |
Avalyn Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 1, 2026 | ||||
| Series D | Jul 22, 2025 | ||||
| Series C | Sep 27, 2023 | ||||
| Series B | Apr 27, 2020 | ||||
| Series A | May 15, 2017 | ||||
Seed | Nov 8, 2012 |
Key People
Founding team and executive leadership
Avalyn Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series D |
| Perceptive Advisors | Series C, Series D |
| Heartland Healthcare Capital | Series C |
| Eventide Funds | Series D, Series C |
| Xontogeny | Series C |
| F-Prime Capital | Series C, Series B, Series A |
| Edmond de Rothschild | Series A |
Recent news
Latest coverage and updates
- hiresSep 16, 2026
Avalyn Pharma Inc. hired Bob as Board of Directors on Sep 16th '26.
- hiresSep 16, 2026
Avalyn Pharma Inc. hired Robert (Bob) J. Meyer as Board of Directors on Sep 16th '26.
- attends_eventSep 8, 2026
Avalyn Pharma Inc. attended event ERS Congress 2026 on Sep 5th '26.
- is_developingAug 24, 2026
Avalyn Pharma Inc. will develop AP03 on Sep 7th '26.
- attends_eventAug 24, 2026
Avalyn Pharma Inc. attended event European Respiratory Society (ERS) International Congress 2026 on Sep 5th '26.
Avalyn Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access